Finding the right clinical trial can be a overwhelming process for patients already dealing with serious health conditions. Two health technology companies are now working together to make that search easier and more effective.
b.well Connected Health and myTomorrows announced a partnership that connects b.well’s massive health data platform with myTomorrows’ AI-powered clinical trial matching technology. The goal is to help patients find relevant trials faster while reducing the administrative burden that often prevents people from participating in potentially life-saving research.
How the partnership works
b.well’s platform pulls together health data from nearly 2.4 million healthcare providers, more than 330 health plans, state health information exchanges, labs, pharmacies, and over 350 wearable devices and health sensors. This creates complete, verified health records for patients who choose to participate.
myTomorrows adds its proven AI-powered screening technology to automatically match patients with relevant clinical trials based on their health data. The system eliminates duplicate data collection and helps patients and their care teams discover all available options without the usual paperwork headaches.
Why this matters for patients and the industry
Clinical trial recruitment has long been a bottleneck in drug development. Many promising treatments take years longer to reach patients because trials struggle to find eligible participants. At the same time, patients often miss out on potentially helpful treatments because they don’t know about relevant trials or get overwhelmed by complex screening processes.
“I know firsthand that a patient and their family will move mountains to access a clinical trial that could change their outcome. But the system hasn’t been set up to allow that,” said Kristen Valdes, founder and CEO of b.well. “Through this collaboration, patients have the power to choose to share their data to find out if there is a trial that could help them.”
For pharmaceutical companies and research sites, the partnership addresses several key challenges:
- Faster enrollment of diverse patient populations
- Reduced recruitment time and costs
- Better reach into different communities
- Less administrative overhead for trial sites
Broader industry implications
This partnership reflects a growing trend in healthcare toward using real-time health data to speed up medical research and reduce administrative friction. As more health systems adopt interoperable data standards like FHIR, companies can build platforms that actually talk to each other instead of creating more data silos.
“By combining our clinical trial matching expertise with b.well’s ability to unify and activate patient health data, we can reach more patients, in more communities, and remove the friction that has historically kept them from accessing emerging treatments,” said Michel van Harten, CEO at myTomorrows.
The companies say they plan to continue developing new features that bring together health data unification and clinical trial matching technology. If successful, this type of partnership could become a model for how the industry approaches patient recruitment for medical research.